Erina en es it fr

Erina Brand names, Erina Analogs

Erina Brand Names Mixture

  • No information avaliable

Erina Chemical_Formula


Erina RX_link

No information avaliable

Erina fda sheet

Erina msds (material safety sheet)

Erina Synthesis Reference

No information avaliable

Erina Molecular Weight

309.469 g/mol

Erina Melting Point

< 25 oC

Erina H2O Solubility

Soluble as HCl salt

Erina State


Erina LogP


Erina Dosage Forms

Tablets (oral, 1 mg)

Erina Indication

Used for the symptomatic treatment of parkinsonism.

Erina Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Erina Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Erina side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Erina Patient Information

Erina Organisms Affected

Humans and other mammals